Peripheral Aneurysms

Background

Summary: Peripheral aneurysms of the lower extremities are uncommon, but popliteal artery aneurysms (PAA) are the most frequent true peripheral arterial aneurysm and are clinically important because their dominant complications are thrombosis and distal embolization leading to acute limb ischemia and chronic limb-threatening ischemia rather than rupture. ^{[1] [2] [3]}

In contrast to 4abdominal aortic aneurysm, where rupture risk drives many intervention thresholds, the management strategy for PAA prioritizes:

• Prevention of thromboembolism and limb loss through timely repair when indicated. ^{[3] [4]}
• Assessment and optimization of inflow/outflow ("runoff") because runoff strongly influences patency and limb outcomes after either open or endovascular repair. ^{[2] [3]}
• Recognition of systemic aneurysmal disease (frequent association with contralateral PAA and 4AAA), prompting structured screening and lifelong follow-up. ^{[1] [5] [3]}

Contemporary care should integrate guideline-based thresholds for elective repair, evidence-based perioperative cardiovascular risk reduction (antiplatelet therapy and high-intensity statin therapy), and a defined duplex ultrasound surveillance pathway for both unrepaired aneurysms and post-repair reconstructions. ^{[6] [7] [3]}

Etiology and Risk Factors

• Atherosclerosis (most common). ^[2]
• Connective tissue disorders (Marfan, Ehlers-Danlos, Loeys-Dietz).
• Trauma or iatrogenic injury.
• Infection (mycotic aneurysm, rare).
• Male sex, age >65, smoking, hypertension, family history of aneurysms. ^[2]

Pathophysiology

• Progressive wall weakening → dilatation. ^[2]
• Popliteal artery special risk: confined space behind knee → higher risk of thrombosis and compression. ^[2]
• Thrombosis and embolism: mural thrombus forms, may occlude lumen or embolize distally. ^[1]
• Compression: nerve (neuropathy), vein (12VTE), or artery (claudication). ^[2]

Clinical Presentation

• Asymptomatic: detected incidentally by imaging or physical exam (pulsatile mass).
• Symptomatic:
• Claudication, rest pain.
• Acute limb ischemia from thrombosis or embolization; ^[1] classified by 10Rutherford grade (Ch. 10).
• Distal embolization → 'blue toe' syndrome, non-healing ulcers.
• Rare: rupture (unlike AAA). ^[1]
• Compression symptoms: DVT may occur from popliteal vein compression—^[2] see 12Ch. 12 for management.

Physical exam: pulsatile mass in popliteal fossa; may be bilateral. ^[1]

Non-Invasive Assessment

Preferred initial test

• Duplex ultrasound (DUS) is first-line for diagnosis and surveillance because it defines aneurysm diameter, mural thrombus, and flow characteristics, and can assess inflow/outflow noninvasively. ^[3]

What to document on DUS (recommended minimum dataset)

• Maximum aneurysm diameter (outer-to-outer wall). ^[3]
• Presence and extent of mural thrombus (qualitative and, when feasible, circumferential burden). ^[2]
• Inflow disease (SFA) and outflow/runoff (tibial vessels), including evidence of distal embolization. ^[3]
• Baseline physiologic status using ABI/TBI when ischemic symptoms or distal disease are suspected (see 10Ch. 10). ^{[8] [6]}

Cross-sectional imaging for planning

• CTA is preferred for preoperative planning when repair is contemplated, particularly to map landing zones (endovascular), define calcification/tortuosity, and characterize tibial runoff. ^[3]
• MRA is appropriate when iodinated contrast is contraindicated or to reduce radiation burden, acknowledging typical limitations in heavily calcified vessels. ^{[9] [3]}

Catheter angiography (DSA)

• Digital subtraction angiography (DSA) is reserved for intra-procedural guidance or when noninvasive imaging is discordant with clinical findings; it also enables simultaneous treatment of distal emboli or tibial lesions. ^{[10] [3]}

Screening

Associated aneurysm screening in patients with PAA

Because PAA frequently clusters with other aneurysms, all patients diagnosed with a true PAA should undergo systematic screening for additional aneurysms using noninvasive imaging. ^{[1] [3] [5]}

Recommended screening targets and modalities

• Contralateral popliteal artery:

• DUS is preferred to confirm bilaterality, define size, and identify thrombus. ^{[1] [3]}

• Abdominal aorta (AAA screening):

• Abdominal ultrasound is first-line screening. ^[5]
• CTA is reserved for operative planning, equivocal ultrasound, or when cross-sectional imaging is already being obtained for lower-extremity planning. ^{[3] [5]}

• Femoral aneurysms (common femoral / superficial femoral):

• Consider targeted DUS or CTA review of the femoral segment given frequent multi-level aneurysmal disease. ^{[3] [4]}

Clinical implication

• Discovery of associated aneurysms alters surveillance burden and may change repair sequencing (for example, symptomatic/large AAA versus threatened limb from PAA). ^{[5] [3]}

Indications for repair

PAA repair indications (guideline-based framework)

Patient- and anatomy-specific modifiers (practical guidance)

• Vein conduit availability strongly influences open bypass durability; in good-risk patients with usable great saphenous vein, open repair is often favored for long-term patency. ^{[2] [3]}
• Endovascular suitability requires adequate proximal and distal landing zones and an understanding of knee-flexion dynamics across the popliteal segment. ^[3]
• Runoff quality (tibial vessel patency) affects both open and endovascular outcomes and should be assessed explicitly during planning. ^{[3] [2]}

Baseline medical therapy (applies to all PAA patients)

• Treat as systemic atherosclerotic disease: high-intensity statin therapy and antiplatelet therapy unless contraindicated. ^{[6] [7]}
• Smoking cessation counseling should be routine given adverse limb and survival outcomes in symptomatic peripheral arterial disease cohorts. ^[12]

Open repair (gold standard)

Open repair (bypass with aneurysm exclusion)

Technique (common approach)

• Proximal and distal control with ligation/exclusion of the aneurysm.
• Bypass from superficial femoral artery to distal popliteal (or tibial target when needed) with:

• Autologous vein preferred (reversed or in situ great saphenous vein). ^{[3] [2]}
• Prosthetic conduit reserved for selected patients when vein is unavailable, generally with inferior durability in below-knee targets. ^[2]

Approach selection (practical)

• Medial approach facilitates longer bypasses and tibial targets when distal embolization/runoff disease is present. ^[2]
• Posterior approach may be used for selected aneurysms confined to the popliteal fossa where direct aneurysm handling is required (for example, compressive symptoms), but is less flexible for tibial targets. ^[2]

Outcomes and durability

• In elective settings with good conduit and runoff, open repair provides durable long-term patency and limb salvage, historically in the 70-90% 5-year range in surgical series. ^[13]
• Presentation matters: acute thrombosis/embolization and poor runoff are associated with worse patency and higher reintervention risk. ^{[3] [2]}

Antithrombotic therapy and risk reduction

• Long-term single antiplatelet therapy and statin therapy are generally recommended for atherosclerotic PAD risk reduction after infrainguinal bypass. ^{[6] [7]}
• Consideration of intensified antithrombotic strategies should be individualized based on bleeding risk and the type of reconstruction (see 10Ch. 10). ^{[14] [15]}

Postoperative surveillance

• Structured duplex surveillance improves detection of clinically significant graft stenosis and supports secondary patency. ^{[16] [3]}

Endovascular repair

Endovascular repair (covered stent-graft exclusion)

Covered stent-grafts can exclude a PAA with lower early physiologic stress and shorter recovery in selected patients, but durability is sensitive to anatomy and knee-flexion biomechanics across the popliteal segment. ^{[3] [17] [18]}

When to consider endovascular repair

• Elevated operative risk or limited life expectancy. ^[3]
• No adequate autologous vein conduit. ^{[3] [2]}
• Favorable anatomy:

• Adequate proximal/distal landing zones. ^[3]
• Acceptable runoff, or a plan to address tibial disease/embolization when present. ^[3]

Limitations and expected outcomes

• Compared with vein bypass, endovascular repair often has higher reintervention rates and inferior long-term primary patency in many series and reviews, emphasizing the need for careful patient selection and surveillance. ^{[19] [3]}
• Early series commonly report ~60-70% primary patency at approximately 3 years, with secondary interventions improving limb outcomes. ^{[17] [19]}

Antithrombotic therapy (pragmatic)

• Antiplatelet therapy is generally used after lower-extremity endovascular interventions; dual-pathway inhibition (low-dose rivaroxaban plus aspirin) reduces major adverse limb events after revascularization in appropriate patients but must be balanced against bleeding risk. ^{[6] [15]}

Surveillance requirement

• Endovascular PAA repair mandates more intensive duplex surveillance than elective open bypass because of edge stenosis, thrombosis risk, and potential deformation with knee flexion. ^[3]

Hybrid approaches

• Limited use; occasionally combined ligation and endograft. ^[2]

Acute limb ischemia due to PAA thrombosis

Acute limb ischemia (ALI) from thrombosed/embolizing PAA

ALI from PAA is most commonly due to thrombosis or distal embolization from mural thrombus and requires urgent limb-focused management plus definitive aneurysm exclusion to prevent recurrence. ^{[2] [3]}

Initial actions (do not delay)

1. Immediate systemic anticoagulation with IV unfractionated heparin unless contraindicated. ^[2]
2. Rapid clinical staging using Rutherford ALI categories (see 10Ch. 10). ^[2]
3. Expedite imaging to guide therapy: DUS for rapid confirmation and inflow/outflow assessment, with CTA when procedural planning is needed. ^[3]

Revascularization strategy (typical)

• Viable or marginally threatened limb (Rutherford I-IIa):

• Consider catheter-directed thrombolysis and/or adjunctive aspiration/mechanical thrombectomy to restore runoff, followed by definitive PAA repair (open bypass with exclusion in many cases; endovascular exclusion in selected anatomy/patients). ^{[3] [2] [20]}

• Immediately threatened limb (Rutherford IIb):

• Proceed directly to urgent open thrombectomy and bypass (often with tibial target) and aneurysm exclusion; thrombolysis is less favored due to time sensitivity. ^{[3] [2]}

• Irreversible ischemia (Rutherford III):

• Revascularization is generally not appropriate; proceed with amputation planning and systemic stabilization (see 10Ch. 10). ^[2]

Key principle

• Reperfusion alone is insufficient: the aneurysm must be excluded/treated to reduce recurrent embolization or rethrombosis. ^[3]

Follow-up

PAA surveillance protocols (unrepaired and after repair)

Actionable surveillance findings (practical triggers)

• Hemodynamically significant graft stenosis on duplex (velocity criteria and waveform change) should prompt timely evaluation for revision to maintain patency. ^{[21] [16]}
• After endovascular exclusion, new symptoms, reduced ABI/TBI, or duplex evidence of edge stenosis/thrombosis warrants expedited reintervention planning. ^{[3] [8]}

Duration of follow-up

• Maintain lifelong surveillance, including contralateral popliteal and abdominal aortic screening/monitoring, due to frequent multi-aneurysm association. ^{[1] [5] [3]}

Tables

Table 5.1. Clinical Manifestations of Popliteal Aneurysms ^[2]

Table 5.2. Open vs Endovascular PAA Repair (patient selection and expectations) ^{[3] [4] [19]}

Table 5.3. Medical Therapy for PAA Patients (systemic risk reduction and post-revascularization) ^{[6] [7] [22] [15] [14]}

Natural history and risk stratification of asymptomatic popliteal artery aneurysms (PAA)

Asymptomatic popliteal artery aneurysms most often progress to thrombotic or embolic events rather than rupture. ^[1] Risk increases with larger diameter, intraluminal thrombus burden, and poor distal runoff. ^[3] Rupture is rare compared to abdominal aortic aneurysms. ^[1] These factors inform thresholds for elective repair and surveillance strategies.

Explicit evidence-based thresholds for elective repair (symptomatic vs asymptomatic)

Evidence-based thresholds guide the decision for elective repair. All symptomatic popliteal artery aneurysms should be repaired regardless of size. ^[3] For asymptomatic aneurysms, elective repair is generally recommended at ≥25 mm. ^[3] Earlier repair should be considered for aneurysms measuring 20–24 mm when accompanied by significant intraluminal thrombus, documented distal embolization, rapid growth, or compromised distal runoff. ^[3] Treatment decisions must be individualized based on patient risk profile and surgical candidacy.

Structured surveillance protocols (by aneurysm size and after repair)

Surveillance protocols should be tailored to aneurysm size, thrombus burden, and treatment modality. For unrepaired popliteal artery aneurysms measuring <20–25 mm without thrombus, duplex ultrasound surveillance is recommended every 6–12 months. The surveillance interval should be shortened if thrombus develops, growth is documented, or symptoms arise. ^[3] After open bypass, duplex ultrasound is recommended at 1, 6, and 12 months, then annually thereafter. ^[3] After endovascular repair, more intensive surveillance is warranted with duplex ultrasound at 1, 3, 6, and 12 months, followed by every 6–12 months long-term, with particular attention to stent-graft compression or kinking during knee flexion. ^[3]

Comparative outcomes: open vs endovascular repair with patient selection

Open bypass with autologous vein conduit remains the gold standard for durability, particularly in good-risk surgical candidates with adequate vein and distal runoff. ^[19] Long-term patency rates of 70–90% at 5 years have been consistently reported with vein bypass. ^[13] Endovascular repair with covered stent grafts offers advantages of lower perioperative morbidity and shorter hospital length of stay, ^[18] making it attractive for high-risk patients or those lacking suitable vein conduit. However, endovascular repair is associated with higher reintervention rates and inferior long-term patency compared to open bypass, ^[19] particularly in the challenging environment across the knee joint. Anatomic suitability requires adequate proximal and distal landing zones and careful consideration of stent-graft deformation dynamics with knee flexion. Reported primary patency at 3 years commonly ranges from 60–70% in early series, ^[17] with secondary interventions improving overall limb salvage rates.

Associated aneurysm screening beyond AAA (contralateral popliteal and femoral aneurysms) with modality

The high frequency of multiple aneurysms in patients with popliteal artery aneurysms mandates systematic screening. Contralateral popliteal artery imaging should be performed in all patients, with duplex ultrasound as the preferred modality. ^[1] Up to 50% of patients will have bilateral popliteal aneurysms. ^[1] Screening for 4abdominal aortic aneurysm is essential, as the association occurs in up to 40% of cases; ^[1] abdominal ultrasound is the recommended first-line imaging modality, with computed tomography angiography reserved for operative planning or when ultrasound findings are equivocal. Assessment for concomitant femoral artery aneurysms should also be considered given the frequent clustering of peripheral aneurysms in affected individuals. ^[3]